SEC Form 4/A · accession 0001104659-15-003340
Radius Health, Inc. · RDUS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Morana Jovan-Embiricos
Director · 10% Owner
Period of report
Jan 8, 2015
Accepted (ET)
Jan 20, 2015 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001428522
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock WarrantF2,F3,F1 | $14.004 | Jan 8, 2015 | J | 89,261 | D | Apr 23, 2013 | Apr 23, 2018 | Common Stock | 89,261 | 267,786 | I |
Explanation of responses
- F1The Form 4 filed on January 12, 2015 incorrectly stated the exercise price of the Common Stock Warrant as $2.694. This amendment is being filed to correct the exercise price.
- F2Reflects a distribution by F2 Bioscience III, L.P. ("F2 Bioscience III") to a limited partner pursuant to a discretionary election.
- F3The reported securities are owned directly by F2 Bioscience III. F2 Biosciences GP Ltd. ("F2 GP") is the General Partner of F2 Bioscience III. Globeways Holdings Limited is a member of F2 GP. The reporting person is a beneficial owner of Globeways Holdings Limited. The reporting person disclaims beneficial ownership of the securities reported herein except to the extent of her pecuniary interest therein.